Summary
Metabolism of 4-[1-(2-fluoro-4-biphenylyl)ethyl]-2-methylaminothiazole (SM-8849), a novel immunomodulatory agent, in rats was investigated. By co-chromatography with authentic samples, desmethylated (SM-8800)p-hydroxylated (SL-5512) and desmethylated-p-hydroxylated SM-8849 (SL-5515) were detected in the bile. Thermospray mass spectrometry (TSP-MS) analysis of five metabolites isolated from the bile revealed molecular ions of both conjugates (glucuronides and a sulfate) and their aglycones. Aglycone structures were determined by comparison of their product spectra with those of authentic standards. Further analyses of conjugation sites were carried out by1H-NMR including differential NOE. As a result, the sulfate of SL-5515 (5515-S), the N-glucuronides of SL-5512 and SM-8849 (5512-NG and 8849-NG, respectively), the glucuronide of SL-5512 (5512-G) and the O-glucuronide of 4-hydroxy-3-methoxy-SM-8849 (CatOMe-OG) were identified. In addition, N-methylthiourea was identified in urine by LC/MS/MS.
Similar content being viewed by others
References
Abe C., Nishikaku F., Koga Y. (1991): Effects of SM-8849 on spontaneous arthritis in MRL/1 mice and type II collagen-induced arthritis in DBA/1J mice. Int. J. Immunother., 7, 1–8.
Nishikaku Y., Koga Y. (1991): Alteration in progression of murine autoimmune disease by treatment with a novel immunomodulator, SM-8849. Int. J. Immunopharmacol., 13, 445–454.
Nishikaku F., Koga Y. (1993): Suppression of murine collagen-induced arthritis by treatment with a novel thiazole derivative, SM-8849. Immunopharmacology, 25, 65–74.
Nishikaku F., Nakamura K., Kashiwazaki S., Koga Y. (1994): Prevention of spontaneous polyarthritis in NBZ/KN mice by treatment with a novel thiazole derivative, SM-8849. Drugs Exp. Clin. Res., 20, 85–92.
Mico B.A., Swagzdis J.E., Federowicz D.A., Straub K. (1986): Functional group metabolism of dopamine-2 agonists: conversion of 4-(2-di-n-propylaminoethyl)-2-(3H)-indolone to 4-(2-di-n-propylaminoethyl)-7-hydroxy-2-(3H)-indolone. J. Pharm. Sci., 75, 929–933.
Rudwicz P., Straub K.M. (1986): Rapid structure elucidation of catecholamine conjugates with tandem mass spectrometry. Anal. Chem., 58, 2928–2934.
Brashear W.T., Kuhnert B.R., Wei R. (1990): Structural determination of the conjugated metabolites of ritodrine. Drug Metab. Dispos., 18, 488–493.
Jackson C.J., Hubbard J.W., McKay G., Cooper J.K., Hawes E.M., Midha K.K. (1991): Identification of phase I and phase II metabolites of fluphenazine in rat bile: intact glucuronide and sulfate conjugates. Drug Metab. Dispos., 19, 188–193.
Yabuki M., Mine T., Iba K., Nakatsuka I., Yoshitake A. (1993): Metabolism of a tetrahydroaminoacridine derivative (SM-10888) in rat: structural analysis of an N-glucuronide of SM-10888 and an O-glucuronide of hydroxylated SM-10888 by FAB-MS/MS. Xenobiotica, 12, 1367–1375.
Risdall P.C., Adams S.S., Crampton E.L., Marchant B. (1978): The disposition and metabolism of flurbiprofen in several species including man. Xenobiotica, 8, 691–704.
Maguire J.H., Kraus B.L., Buttler T.C., Dudly K.H. (1981): Stereochemical aspects of the metabolism of 5-ethyl-5-phenylhydantoin (NILVANOL) in the dog. Drug Metab. Dispos., 9, 393–401.
Andersen J.V., Dalgaard L., Hansen S.H. (1989): Enzymic synthesis of two glucuronides of the hydroxyl oxazole GABA-agonist, THIP, and the in vivo glucuronidation of THIP in rat. Xenobiotica, 19, 1399–1406.
Chatfield D.H., Hunter W.H. (1973): The metabolism of acetamidothiazoles in the rat: 2-acetamido-2-acetamido-4-methyl-and 2-acetamido-4-phenyl-thiazole. Biochem. J., 134, 869–878.
Chatfield D.H., Hunter W.H. (1973: The metabolism of acetamidothiazoles in the rat: 2-acetamido-4-chloromethylthiazole. Biochem. J., 134, 879–884.
Mutlib A.E., Chui Y.C., Young L.M., Abbott F.S. (1992): Characterization of metabolites of xylazine produced in vivo and in vitro by LC/MS/MS and GC/MS. Drug. Metab. Dispos., 20, 840–848.
Mizutani T., Yoshida K., Kawazoe S. (1994): Formation of toxic metabolites from thiabendazole and other thiazoles in mice: identification of thioamides as ring cleavage products. Drug Metab. Dispos., 22, 750–755.
Liberti P., Stanbury J.B. (1971): The pharmacology of substances affecting the thyroid gland: Annu. Rev. Pharmacol., 11, 113–142.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yabuki, M., Shimakura, J., Ito, M. et al. Metabolism of 4-[1-(2-fluoro-4-biphenylyl)ethyl]-2-methylaminothiazole (SM-8849) in rats. European Journal of Drug Metabolism and Pharmacokinetics 22, 25–33 (1997). https://doi.org/10.1007/BF03189781
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189781